- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cancer risk in immune-mediated inflammatory diseases (IMID) ; volume:12 ; number:1 ; day:29 ; month:8 ; year:2013 ; pages:1-12 ; date:12.2013
Molecular cancer ; 12, Heft 1 (29.8.2013), 1-12, 12.2013
- Creator
-
Beyaert, Rudi
Beaugerie, Laurent
Van Assche, Gert
Brochez, Lieve
Renauld, Jean-Christophe
Viguier, Manuelle
Cocquyt, Veronique
Jerusalem, Guy
Machiels, Jean-Pascal
Prenen, Hans
Masson, Pierre
Louis, Edouard
De Keyser, Filip
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-12-98
- URN
-
urn:nbn:de:101:1-2021082220064528710651
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beyaert, Rudi
- Beaugerie, Laurent
- Van Assche, Gert
- Brochez, Lieve
- Renauld, Jean-Christophe
- Viguier, Manuelle
- Cocquyt, Veronique
- Jerusalem, Guy
- Machiels, Jean-Pascal
- Prenen, Hans
- Masson, Pierre
- Louis, Edouard
- De Keyser, Filip
- SpringerLink (Online service)
Other Objects (12)
Immune monitoring and treatment in immune-mediated inflammatory diseases
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Recent advances of exosomes in immune-mediated eye diseases
Immune monitoring and treatment in immune-mediated inflammatory diseases
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Recent advances of exosomes in immune-mediated eye diseases
Immune monitoring and treatment in immune-mediated inflammatory diseases
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease